Cold Chain Smart Solutions Conference

Fleming Europe19 - 21 January 2011, Barcelona, Spain
The Cold Chain Smart Solutions Conference is the perfect place to get up to speed with the latest regulations, technology and processes that are necessary to operate a cost-effective and compliant temperature controlled supply chain.

Due to greater temperature ranges and novel biotech drugs coming onto market the number of cold chain shipments by air, road and sea continue increasing. Temperature controlled and pharmaceutical shipping are widely expected to lead the recovery in terms of growth rates. Therefore the most immediate investment priorities of pharmaceutical, shipper, wholesaler companies and CMOs should include cold chain capabilities.

By attending you will have the chance to listen to conference presentations, panel discussions, specialist discussion forums, tailor-made streams about the burning topics of the industry - such as the most updated regulatory roadmap, quality systems and agreements, RF-enabled product visibility, electronic temperature monitoring, satellite tracking, "Last mile" issues, new market focus on Asia, shipping by ocean, cold chain packaging & shipping smart solutions: PCM, going green, active ULDs, battery-assisted passive RFID, etc.

In the frame of a highly interactive Post-Conference Workshop you will gain an insight into the newest real-life strategies how to mitigate the risks and optimize the cold chain costs efficaciously.

Furthermore, you will have excellent opportunities to network with temperature controlled supply chain stakeholders from:

  • Pharmaceutical, Biotech and Medical Device Manufacturers
  • Transportation Providers
  • Government Healthcare Agencies and Shippers
  • Freight forwarders
  • Packaging Partners
  • Wholesalers

As a comprehensive and one-of-its kind event, the Cold Chain Smart Solutions Conference will address the most urgent challenges of the global marketplace for the storage and distribution of temperature sensitive pharmaceuticals, biopharmaceuticals, vaccines, etc.

For further information and brochure request, please visit:
http://www.flemingeurope.com/life-science-conferences/europe/cold-chain-smart-solutions

About Fleming Europe conferences
Fleming Europe conferences are events linking business with intelligence. Carefully designed to provide key strategic business information and the best networking opportunities for the participants, our B2B conferences are highly interactive. Number of delegates from specialized industry sectors - brought together by Fleming Europe - become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

GSK reaches agreement with Novartis to acquire ful…

GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that it has reached an agreement with Novartis for the buyout of Novartis' 36.5% stake in their Consumer Healthcare Jo...

Canadian neuroscientists say daily ibuprofen can p…

A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enou...

First proof a synthesized antibiotic is capable of…

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time - and could lea...

Merck partners with Medisafe to help improve medic…

Merck, a leading science and technology company, today announced a new collaboration with US-based Medisafe to help its cardiometabolic patients better manage medication ...

Novartis teams up with Harvard to develop next gen…

Novartis announced today that it is teaming up with scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Can...

Phase III data in The Lancet show Novartis siponim…

Novartis today announced that the full results from the Phase III EXPAND study of oral, once-daily siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS) w...

Taking a standard prostate cancer drug with food b…

By taking a high-cost drug with a low-fat meal - instead of on an empty stomach, as prescribed - prostate cancer patients could decrease their daily dose, prevent digesti...

North and south cooperation to combat tuberculosis

Tuberculosis can be cured and could be eradicated. For this to happen, however, patients have to receive the right treatment. Researchers at the Makerere University and t...

New immunotherapy for lung cancer shows promise of…

In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at contro...

Lokelma approved in the EU for the treatment of ad…

AstraZeneca today announced that the European Commission has granted marketing authorisation for Lokelma (formerly ZS-9, sodium zirconium cyclosilicate) for the treatment...

New targeted therapy schedule could keep melanoma …

Skin melanoma, a particularly insidious cancer, accounts for the vast majority skin cancer deaths and is one of the most common cancers in people under 30. Treatment for ...

Personalized tumor vaccine shows promise in pilot …

A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and...